Fig. 1From: Alantolactone inhibits cell autophagy and promotes apoptosis via AP2M1 in acute lymphoblastic leukemiaALT inhibits the proliferation of ALL cells. ALL cell lines (a) BV173, (b) JM-1, (c) NALM1, (d) NALM6, (e) RS6 and (f) SUPB15 were treated with 1, 5 and 10 μM ALT for 24 h and cell viability was assessed. Data are presented as the mean ± standard deviation of three repeats. *P < 0.05, **P < 0.01 vs. control. ALL, acute lymphoblastic leukemia; ALT, alantolactoneBack to article page